» Articles » PMID: 37316634

Pancreatic Cancer Epigenetics: Adaptive Metabolism Reprograms Starving Primary Tumors for Widespread Metastatic Outgrowth

Overview
Specialty Oncology
Date 2023 Jun 14
PMID 37316634
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer is a paradigm for adaptation to extreme stress. That is because genetic drivers are selected during tissue injury with epigenetic imprints encoding wound healing responses. Ironically, epigenetic memories of trauma that facilitate neoplasia can also recreate past stresses to restrain malignant progression through symbiotic tumor:stroma crosstalk. This is best exemplified by positive feedback between neoplastic chromatin outputs and fibroinflammatory stromal cues that encase malignant glands within a nutrient-deprived desmoplastic stroma. Because epigenetic imprints are chemically encoded by nutrient-derived metabolites bonded to chromatin, primary tumor metabolism adapts to preserve malignant epigenetic fidelity during starvation. Despite these adaptations, stromal stresses inevitably awaken primordial drives to seek more hospitable climates. The invasive migrations that ensue facilitate entry into the metastatic cascade. Metastatic routes present nutrient-replete reservoirs that accelerate malignant progression through adaptive metaboloepigenetics. This is best exemplified by positive feedback between biosynthetic enzymes and nutrient transporters that saturate malignant chromatin with pro-metastatic metabolite byproducts. Here we present a contemporary view of pancreatic cancer epigenetics: selection of neoplastic chromatin under fibroinflammatory pressures, preservation of malignant chromatin during starvation stresses, and saturation of metastatic chromatin by nutritional excesses that fuel lethal metastasis.

Citing Articles

Carcinogenic effect of human tumor-derived cell-free filtrates in nude mice.

Berlanga-Acosta J, Arteaga-Hernandez E, Garcia-Ojalvo A, Duvergel-Calderin D, Rodriguez-Touseiro M, Lopez-Marin L Front Mol Biosci. 2024; 11:1361377.

PMID: 38698774 PMC: 11063718. DOI: 10.3389/fmolb.2024.1361377.


Alteration of chromosome structure impacts gene expressions implicated in pancreatic ductal adenocarcinoma cells.

Han W, Shi D, Yang Q, Li X, Zhang J, Peng C BMC Genomics. 2024; 25(1):206.

PMID: 38395755 PMC: 10885383. DOI: 10.1186/s12864-024-10109-4.

References
1.
He D, Feng H, Sundberg B, Yang J, Powers J, Christian A . Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Mol Cell. 2022; 82(16):3045-3060.e11. PMC: 9391305. DOI: 10.1016/j.molcel.2022.06.005. View

2.
Olivares O, Mayers J, Gouirand V, Torrence M, Gicquel T, Borge L . Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017; 8:16031. PMC: 5504351. DOI: 10.1038/ncomms16031. View

3.
Tasdogan A, Ubellacker J, Morrison S . Redox Regulation in Cancer Cells during Metastasis. Cancer Discov. 2021; 11(11):2682-2692. PMC: 8563381. DOI: 10.1158/2159-8290.CD-21-0558. View

4.
Halbrook C, Lyssiotis C, Pasca di Magliano M, Maitra A . Pancreatic cancer: Advances and challenges. Cell. 2023; 186(8):1729-1754. PMC: 10182830. DOI: 10.1016/j.cell.2023.02.014. View

5.
Kerk S, Papagiannakopoulos T, Shah Y, Lyssiotis C . Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment. Nat Rev Cancer. 2021; 21(8):510-525. PMC: 10257891. DOI: 10.1038/s41568-021-00375-9. View